Orange Book product · Brand (NDA)
CARDURA XL
DOXAZOSIN MESYLATE
At a glance
Feb 22, 2005
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 22, 2005
21 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXAZOSIN MESYLATE
Strength
EQ 4MG BASE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 021269
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1990CARDURABrand (NDA)
NDA 019668 · VIATRIS
- 2024DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 212329 · UNICHEM
- 2022DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 212727 · RISING
- 2018DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 209013 · SOMERSET THERAPS LLC
- 2018DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 205210 · HERITAGE PHARMA
- 2017DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 208719 · ZYDUS PHARMS
- 2014DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 202824 · ACCORD HLTHCARE
- 2004DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 076161 · STRIDES PHARMA INTL
- 2001DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 075750 · PLIVA
- 2001DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 075353 · TEVA
- 2000DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 075509 · AUROBINDO PHARMA USA
- 2000DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 075574 · ACTAVIS ELIZABETH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
